跳至主要内容
临床试验/NCT03926520
NCT03926520
招募中
不适用

Effect and Safety of Electroconvulsive Therapy Plus Usual Care for the Acute Management of Severe Agitation in Dementia

Brent Forester10 个研究点 分布在 1 个国家目标入组 50 人2021年1月28日

概览

阶段
不适用
干预措施
Electroconvulsive Therapy (ECT)
疾病 / 适应症
Alzheimer Dementia
发起方
Brent Forester
入组人数
50
试验地点
10
主要终点
CMAI total score
状态
招募中
最后更新
4天前

概览

简要总结

This study will explore the effect of ECT treatments plus usual care (ECT+UC) in reducing severe agitation in patients with moderate to severe dementia including Alzheimer's Disease, Vascular dementia, Frontotemporal dementia, and Dementia with Lewy Bodies. The study will also determine the tolerability/safety outcomes of ECT+UC.

详细描述

This study will be a single-arm, unblinded, non-randomized trial to determine the effect and safety of ECT for severe agitation in moderate to severe stage dementia, while also examining the durability of the acute treatment effect in an exploratory maintenance naturalistic design. We plan to enroll 50 participants with an estimated dropout rate of 20%. We expect 50 participants to complete at least 1 ECT treatment before moving into the 12-month naturalistic follow-up phase.

注册库
clinicaltrials.gov
开始日期
2021年1月28日
结束日期
2026年5月31日
最后更新
4天前
研究类型
Interventional
研究设计
Single Group
性别
All

研究者

发起方
Brent Forester
责任方
Sponsor Investigator
主要研究者

Brent Forester

Principal Investigator

Mclean Hospital

入排标准

入选标准

  • Diagnosis of Dementia, of the following subtypes,
  • Alzheimer's dementia, according to NIA-AA Criteria for dementia
  • Vascular dementia based on:
  • i. History consistent with insidious onset of illness and gradual clinical decline ii. MRI evidence of microvascular ischemic disease (microinfarcts) iii. Physical and neurological examination do not indicate current or prior stroke c. Frontotemporal dementia d. Dementia with Lewy Bodies
  • Mini Mental Status Exam (MMSE) less than or equal to 15
  • Cohen-Mansfield Agitation Inventory Nursing Home Version (CMAI) score of 5 or more on at least one item or score of 4 on two items of aggression or physical nonaggression that holds potentially dangerous consequences including hitting (including self), kicking, grabbing onto people, pushing, throwing things, biting, scratching, spitting, hurting self or other, tearing things or destroying property, making physical sexual advances, trying to get to a different place, or intentional falling (items 1-11, 14, 15) OR one score of 5 or more in items of verbal aggression including screaming, making verbal sexual advances, and cursing or verbal aggression (items 22-24).
  • At least one failed pharmacological intervention to manage behavioral symptoms
  • Medically stable for safe administration of ECT verified by standard physical examination, urinalysis and serum chemistries and brain imaging when clinically indicated
  • Comprehension of English language
  • Authorized legal representative able and willing to give informed consent

排除标准

  • Current diagnosis of co-morbid delirium, measured by the Confusion Assessment Measure (CAM) and by clinical diagnosis
  • Diagnosis of vascular dementia due to stroke, based on:
  • History consistent with abrupt onset and step-wise progression of cognitive and functional decline
  • MRI scan within the past 12 months demonstrating evidence of hemorrhagic and embolic stroke
  • Physical and neurologic examination consistent with current or prior stroke
  • Lifetime or current diagnosis of Schizophrenia, Bipolar Disorder or Schizoaffective Disorder
  • Active substance use disorder within past 6 months
  • Treatment with ECT or other neurostimulation therapies (e.g., TMS or vagal nerve stimulation) within the past 3 months

研究组 & 干预措施

ECT+UC group

ECT with Usual Care

干预措施: Electroconvulsive Therapy (ECT)

结局指标

主要结局

CMAI total score

时间窗: The CMAI will be collected through study completion, about 13 months

The CMAI measures the efficacy of ECT+UC in reducing severe agitation in AD subjects. The CMAI is a 29-item scale with each item ranging from 1-7 in frequency with 7 being the highest and therefore worst outcome.

次要结局

  • Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change Scale (ADCS-CGIC)(The ADCS-CGIC will be collected for one month)
  • Neuropsychiatric Inventory, Clinician Version (NPI-C)(The NPI-C will be collected for one month)
  • Pittsburgh Agitation Scale (PAS)(The PAS will be collected for one month)

研究点 (10)

Loading locations...

相似试验